Dr Reddy’s Laboratories can now launch the generic version of Allegra D-24, an extended release version of blockbuster drug Allegra. It won a key case in the US courts which will allow it to go ahead with a launch, with the possibility of a compensation being awarded by the court, but with the risk of an appeal, which could see the matter well drag on further.
indiabusinessview - Business News, Financial News, Analysis, Commentary, Views, Opinion
indiabusinessview (https://indiabusinessview.com/tag/amri/)